Page last updated: 2024-10-29

avapro and Apnea, Sleep

avapro has been researched along with Apnea, Sleep in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"ARB prevents chronic sleep apnea-enhanced cardiac apoptosis via enhancing survival pathways."1.72Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation. ( Huang, CY; Lee, SD; Lin, CY; Lin, YY; Liou, YF; Pai, PY; Wong, JKS; Wu, XB; Yu, SH, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pai, PY1
Lin, YY1
Yu, SH1
Lin, CY1
Liou, YF1
Wu, XB1
Wong, JKS1
Huang, CY1
Lee, SD1

Other Studies

1 other study available for avapro and Apnea, Sleep

ArticleYear
Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation.
    Sleep & breathing = Schlaf & Atmung, 2022, Volume: 26, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Hypo

2022